Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer—a systematic review and meta-analysis
Top Cited Papers
Open Access
- 18 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 19 (2), 105-123
- https://doi.org/10.1093/humupd/dms051
Abstract
In response to the ongoing debate on the long-term effects of assisted reproduction technologies, such as IVF, we systematically reviewed and meta-analyzed available evidence on the association between controlled ovarian hyperstimulation for IVF and risk of ovarian, endometrial and cervical cancer. Eligible studies were identified and pooled effect estimates for relative risk (RR) were calculated by cancer type among two reference groups (general population or infertile women), through fixed- or random-effects models as appropriate. Nine cohort studies were synthesized, corresponding to a total size of 109 969 women exposed to IVF, among whom 76 incident cases of ovarian, 18 of endometrial and 207 cases of cervical cancer were studied. The synthesis of studies with general population as the reference group pointed to a statistically significant positive association between IVF and increased risk for ovarian (RR = 1.50, 95% confidence interval (CI): 1.17–1.92) and endometrial (RR = 2.04, 95% CI: 1.22–3.43), but not cervical (RR = 0.86, 95% CI: 0.49–1.49) cancers. On the contrary, when infertile women were used as the reference group, no significant associations with ovarian, endometrial or cervical cancer types were noted (RR = 1.26, 95% CI: 0.62–2.55 RR = 0.45, 95% CI: 0.18–1.14 and RR = 5.70, 95% CI: 0.28–117.20, respectively). IVF does not seem to be associated with elevated cervical cancer risk, nor with ovarian or endometrial cancer when the confounding effect of infertility was neutralized in studies allowing such comparisons. Of note, only one study provided follow-up longer than 10 years for the group exposed to IVF. Future cohort studies should preferably use infertile women as the reference group, rely on IVF-registered valid exposure data, adjust for a variety of meaningful confounders and adopt relatively longer follow-up periods before sound conclusions are drawn.Keywords
This publication has 99 references indexed in Scilit:
- Risques de la stimulation ovarienne et du prélèvement ovocytaireGynécologie Obstétrique & Fertilité, 2009
- Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohortBritish Journal of Cancer, 2009
- Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletionThe Lancet Oncology, 2008
- Cancer Risk After Exposure to Treatments for Ovulation InductionAmerican Journal of Epidemiology, 2008
- Immune system involvement in the regulation of ovarian function and augmentation of cancerMicroscopy Research and Technique, 2006
- Endometriosis as a model for inflammation–hormone interactions in ovarian and breast cancersEuropean Journal of Cancer, 2006
- Ovarian stimulation and borderline ovarian tumors: a case-control studyFertility and Sterility, 1998
- Updated projections of infertility in the United States: 1995–2025Fertility and Sterility, 1998
- Ovarian stimulation and granulosa-cell tumourThe Lancet, 1993
- A Controlled Study of Luteinizing Hormone–Releasing Hormone Agonist (Buserelin) for the Induction of Folliculogenesis before in Vitro FertilizationThe New England Journal of Medicine, 1989